Other languages QuidelOrtho Corporation

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
39.64 ^USD	-0.13%		+1.33%	-46.21%

Apr. 02	QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	MT
Apr. 02	QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	MT

QuidelOrtho Shares Fall on Decision to Withdraw FDA 510(k) Submission for Savanna RVP4+ Assay	Apr. 02
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test	Apr. 02
QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test	Apr. 02
QuidelOrtho Receives Canada's Approval for Triage PLGF Test to Detect Pregnancy Complications	Mar. 06
QuidelOrtho Shares Decline Following UBS Downgrade	Mar. 04
Sector Update: Health Care Stocks Mixed in Late Afternoon	Feb. 21
Sector Update: Health Care	Feb. 21
QuidelOrtho Terminates CEO Douglas Bryant, Postpones Investor Day	Feb. 21
QuidelOrtho Corporation Announces CEO Changes	Feb. 21
QuidelOrtho Corporation Announces Changes in Executive Leadership, Effective from February 21, 2024	Feb. 21
Sector Update: Health Care Stocks Gain Late Afternoon	Feb. 14
Sector Update: Health Care Stocks Rise in Afternoon Trading	Feb. 14
Top Midday Decliners	Feb. 14
QuidelOrtho Shares Slump After Analysts Downgrade Stock Following Lower Q4 Results	Feb. 14
Sector Update: Health Care Stocks Edge Higher Premarket Wednesday	Feb. 14
Sector Update: Health Care	Feb. 14
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Traders Recover From Inflation Figures Shock	Feb. 14
Top Premarket Decliners	Feb. 14
QuidelOrtho Q4 Adjusted Earnings, Revenue Fall; 2024 EPS Outlook Lags; Shares Plunge Premarket	Feb. 14
QuidelOrtho Q4 Adjusted Earnings, Revenue Fall; 2024 Outlook Set -- Shares Slump After Hours	Feb. 13

No results for this search